Advantage Investment Management’s Allergan plc AGN Stock Holding History

Advantage Investment Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-63	Closed	-$11K	–	982
2019 Q2	$11K	Hold	63	–	–	0.01%	652
2019 Q1	$9K	Hold	63	–	–	0.01%	677
2018 Q4	$8K	Hold	63	–	–	0.01%	710
2018 Q3	$12K	Hold	63	–	–	0.01%	679
2018 Q2	$11K	Sell	63 -14	-18%	-$2.25K	0.01%	639
2018 Q1	$13K	Buy	77 +4	+5%	+$671	0.01%	633
2017 Q4	$12K	Buy	73 +10	+16%	+$1.79K	﹤0.01%	661
2017 Q3	$13K	Hold	63	–	–	﹤0.01%	645
2017 Q2	$15K	Hold	63	–	–	0.01%	623
2017 Q1	$15K	Hold	63	–	–	0.01%	610
2016 Q4	$13K	Hold	63	–	–	﹤0.01%	591
2016 Q3	$15K	Hold	63	–	–	0.01%	555
2016 Q2	$15K	Hold	63	–	–	0.01%	525
2016 Q1	$17K	Sell	63 -22	-26%	-$6.3K	0.01%	489
2015 Q4	$27K	Hold	85	–	–	0.01%	428
2015 Q3	$23K	Hold	85	–	–	0.01%	425
2015 Q2	$26K	Buy	+85	New	+$25.4K	0.01%	440

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advantage Investment Management's AGN Position: Q3 2019 in Review

Advantage Investment Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 63 shares — an estimated $11K sold.

Advantage Investment Management first reported a position in AGN in Q2 2015 and held it in 17 quarters. The position peaked at $27K in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

Advantage Investment Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
Advantage Investment Management sold 63 Allergan plc shares in Q3 2019, an estimated $11K.
Advantage Investment Management first reported a position in Allergan plc in Q2 2015 and held it in 17 quarters.
Advantage Investment Management's Allergan plc position peaked at $27K in Q4 2015.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.